[1]张弛,李浩,张淑霞,等.急性部分前循环供血区脑梗死患者血清S100β蛋白、8-OHDG,Lp-PLA2水平与rt-PA静脉溶栓再通及卒中后认知功能障碍的关系[J].卒中与神经疾病杂志,2023,30(01):19-25.[doi:10.3969/j.issn.1007-0478.2023.01.004]
　Zhang Chi*,Li Hao,Zhang Shuxia*,et al.Relationship between serum S100β protein, 8-OHDG, LP-PLA2 levels and rt-PA intravenous thrombolytic recanalization and cognitive impairment after stroke in patients with acute partial anterior circulation cerebral infarction[J].Stroke and Nervous Diseases,2023,30(01):19-25.[doi:10.3969/j.issn.1007-0478.2023.01.004]
点击复制

急性部分前循环供血区脑梗死患者血清S100β蛋白、8-OHDG,Lp-PLA2水平与rt-PA静脉溶栓再通及卒中后认知功能障碍的关系()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第30卷
期数:
2023年01期
页码:
19-25
栏目:
论著
出版日期:
2023-03-20

文章信息/Info

Title:
Relationship between serum S100β protein, 8-OHDG, LP-PLA2 levels and rt-PA intravenous thrombolytic recanalization and cognitive impairment after stroke in patients with acute partial anterior circulation cerebral infarction
文章编号:
1007-0478(2023)01-0019-07
作者:
张弛; 李浩; 张淑霞; 于海滨; 王亚姣; 冯社军
063000 唐山弘慈医院有限公司神经内科(张弛 张淑霞 于海滨 王亚姣),重症医学科(李浩); 邯郸市中心医院神经内科(冯社军)
Author(s):
Zhang Chi*;  Li Hao;  Zhang Shuxia*;  et al.
*Department of Neurology, Tangshan Hongci Hospital Limited Company, Tangshan 063000
关键词:
S100β蛋白 8-羟基脱氧鸟苷酸 脂蛋白相关磷脂酶A2 部分前循环供血区梗死 静脉溶栓 认知功能障碍
Keywords:
S100βprotein 8-hydroxydeoxyguanylic acid Lipoprotein associated phospholipase A2 Partial anterior circulation infarction Intravenous thrombolysis Cognitive impairment
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2023.01.004
文献标志码:
A
摘要:
目的 观察急性部分前循环供血区脑梗死(Partial anterior circulation infarction,PACI)患者血清S100β蛋白、8-羟基脱氧鸟苷酸(8-Hydroxydeoxyguanylate,8-OHDG)、脂蛋白相关磷脂酶A2(Lipoprotein associated phospholipase A2,Lp-PLA2)水平变化,分析各指标水平与重组组织型纤溶酶原激活剂(Recombinant tissue plasminogen activator,rt-PA)静脉溶栓效果及12个月内发生卒中后认知功能障碍(Post-stroke cognitive impairment,PSCI)的关系。方法 选取2019年3月-2021年3月在本院静脉溶栓治疗的急性PACI患者127例为研究对象,记录溶栓再通及治疗后12个月内PSCI发生情况,分析血清S100β蛋白、8-OHDG,Lp-PLA2水平与溶栓再通及PSCI发生的关系,并进一步采用Logistic逐步回归分析溶栓再通及PSCI发生的影响因素,并绘制受试者工作特征(Receiver operating characteristic curve,ROC)曲线评价早期预测效能。结果 急性PACI患者rt-PA静脉溶栓后24 h内血管再通者96例(75.59%),血管未再通者31例(24.41%); 发病至溶栓时间、溶栓前美国国立卫生研究院卒中量表(National institutes of health stroke scale,NIHSS)评分及血清S100β蛋白、8-OHDG,Lp-PLA2水平是PACI静脉溶栓血管未再通的独立危险因素(P<0.05)。静脉溶栓治疗后12个月内发生PSCI者50例(39.37%),未发生PSCI者77例(60.63%); FAZEKAS评分、溶栓未再通、溶栓后第7 d NIHSS评分及血清S100β蛋白、8-OHDG,Lp-PLA2水平是PACI静脉溶栓治疗后12个月内PSCI发生的独立危险因素(P<0.05)。NIHSS评分、发病至溶栓时间及FAZEKAS评分等基本临床参数结合血清S100β蛋白、8-OHDG,Lp-PLA2水平预测PACI静脉溶栓再通及溶栓治疗后12个月内PSCI发生的曲线下面积(Area under the curve,AUC)分别为0.889和0.903,明显高于单独预测,具有较高的临床预测价值。结论 急性PACI患者rt-PA静脉溶栓效果及PSCI发生与早期神经炎症及氧化应激反应密切相关,动态监测血清S100β蛋白、Lp-PLA2,8-OHDG水平变化结合NIHSS评分、FAZEKAS评分等基本临床参数对早期预测PACI静脉溶栓效果及PSCI发生、指导临床诊疗及改善预后具有重要意义。
Abstract:
ObjectiveTo observe the changes of serum S100β protein, 8-hydroxydeoxyguanodic acid(8-OHDG), lipoprotein associated phospholipase A2(LP-PLA2)levels in patients with acute partial anterior circulation cerebral infarction(PACI), and to analyze the relationship between the levels of each indicator and the efficacy of intravenous throbolysis of RT-PA and cognitive impairment after stroke(PSCI)within 12 months.Methods A total of 127 patients with acute PACI who received intravenous thrombolytic therapy from March 2019 to March 2021 were adimtted to the study subjects, and to record the occurrence of PSCI within 12 months after thrombolytic recanalization and treatment. To analyze the relationship between serum levels of S100β protein, 8-OHDG and LP-PLA2 and the occurrence of thrombolytic recanalization and PSCI, and the influencing factors of thrombolytic recanalization and PSCI were further analyzed by Logistic stepwise regression, and the receiver operating characteristic(ROC)curve was plotted to evaluate the early prediction efficiency.Results In acute PACI patients, 96 patients(75.59%)were recanalized 24 h after RT-PA intravenous thrombolysis, and 31 patients(24.41%)were not recanalized. The time from onset to thrombolysis, NIHSS score before thrombolysis and serum S100β protein, 8-OHDG and LP-PLA2 levels were independent risk factors for non-recanalization of venous thrombolysis in PACI(P<0.05). PSCI occurred in 50 patients(39.37%)and did not occur in 77 patients(60.63%)within 12 months after intravenous thrombolytic therapy. FAZEKAS score, no recanalization after thrombolytic therapy, NIHSS score and serum S100β protein, 8-OHDG and LP-PLA2 levels at 7 days after thrombolytic therapy were independent risk factors for PSCI within 12 months after intravenous thrombolytic therapy for PACI(P<0.05). NIHSS score, time from onset to thrombolytic therapy, FAZEKAS score and other basic clinical parameters combined with serum S100β protein, 8-OHDG, LP-PLA2 predicted the occurrence of PSCI within 12 months after intravenous thrombolytic therapy and PACI were 0.889 and 0.903, respectively, significantly higher than the prediction alone, it has high clinical predictive value.Conclusion The effect of intravenous thrombolytic rT-PA and the occurrence of PSCI in patients with acute PACI are closely related to early neuroinflammation and oxidative stress response. Dynamic monitoring of serum S100β protein, LP-PLA2 and 8-OHDG levels combined with NIHSS score, FAZEKAS score and other basic clinical parameters is of great significance for early prediction of intravenous throbolysis effect of PACI and occurrence of PSCI, guiding clinical diagnosis and treatment and improving prognosis.

参考文献/References:

[1] Tu J, Wang LX, Wen HF, et al. The association of different types of cerebral infarction with post-stroke depression and cognitive impairment[J]. Medicine(Baltimore), 2018, 97(23): e10919.
[2] Wang A, Zhang Y. Therapeutic effects of alteplase intravenous thrombolysis on different types of acute cerebral infarction: a controlled randomized analysis[J]. Am J Transl Res, 2021, 13(8): 9129-9135.
[3] Talavera B, G mez-Vicente B, Mart nez-Gald mez M, et al. Delayed neurological improvement after full endovascular reperfusion in acute anterior circulation ischemic stroke[J]. Stroke, 2021, 52(7): 2210-2217.
[4] Li Z XZ, Significance of S-100β. CysC and NF-κB in patients with acute cerebral infarction[J]. Exp Ther Med, 2021, 21(2): 149.
[5] 文微微,王燚鑫,张蔚蔚.血清8-OHdG,MnSOD水平与急性缺血性脑卒中患者rt-PA静脉溶栓后认知功能恢复的相关性分析[J].实用药物与临床,2021,24(2):133-137.
[6] Zhang QL, Lu P, Zhang JW. Association of serum lipoprotein-associated phospholipase A2 with vascular dementia after ischemic stroke[J]. Zhonghua Yi Xue Za Zhi, 2018, 98(15): 1171-1175.
[7] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.
[8] 肖静,谭郎敏,潘成德,等.rt-PA静脉溶栓与尿激酶静脉溶栓治疗急性脑梗死的疗效比较研究[J].解放军预防医学杂志,2018,36(4):441-444.
[9] 中国卒中学会,卒中后认知障碍管理专家委员会.卒中后认知障碍管理专家共识[J].中国卒中杂志,2017,12(6):519-531.
[10] 孙胜楠,徐耀,马灿灿,等.急性缺血性脑卒中后认知障碍患者精神行为症状的特征性分析[J].中华老年心脑血管病杂志,2020,22(4):348-351.
[11] Xu S, Lu J, Shao A, et al. Glial cells: role of the immune response in ischemic stroke[J]. Front Immunol, 2020, 11: 294.
[12] Chen H, He Y, Chen S, et al. Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: Applications for natural product efficacy with omics and systemic biology[J]. Pharmacological Research, 2020, 158: 104877.
[13] Wang Y, Hou Y, Li H, et al. A SERS-based lateral flow assay for the stroke biomarker S100-β[J]. Mikrochim Acta, 2019, 186(8): 548.
[14] 陈慧杰,孙东东.血清S-100β神经元特异性烯醇化酶水平与脑卒中患者神经功能损害程度的相关性研究[J].中国实用神经疾病杂志,2021,24(5):420-424.
[15] 陈文华.脑梗死患者血清S100β和神经元特异性烯醇化酶水平与认知功能障碍的关系[J].血栓与止血学,2018,24(4):558-559+562.
[16] Foerch C, Du Mesnil De Rochemont R, Singer O, et al. S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion[J]. J Neurol Neurosurg Psychiatry, 2003, 74(3): 322-325.
[17] Kondo S, Toyokuni S, Tanaka T, et al. Overexpression of the hOGG1 gene and high 8-hydroxy-2'-deoxyguanosine(8-OHdG)lyase activity in human colorectal carcinoma: regulation mechanism of the 8-OHdG level in DNA[J]. Clin Cancer Res, 2000, 6(4): 1394-1400.
[18] 李美珠,朱嫦琳,梁指荣,等.血清8-羟基脱氧鸟苷酸在急性脑梗死诊断中的应用[J].广东医学,2015,36(20):3191-3193.
[19] 杨春,徐玲玲,万春晓.急性脑梗死患者静脉溶栓前后氧化应激表达与功能结局的相关性[J].重庆医学,2022,51(6):910-915.
[20] 张钱林,鲁平,张杰文.血清脂蛋白相关磷酸酶A2与缺血性脑卒中致血管性痴呆的相关性[J].中华医学杂志,2018,98(15):1171-1175.
[21] 郑松娜,张蓉,韩志铁,等.急性脑梗死rt-PA溶栓治疗后血浆BNP与Lp-PLA2水平变化研究[J].交通医学,2019,33(2):148-150.

备注/Memo

备注/Memo:
基金项目:2021年河北省医学科学研究课题计划(20211627)
更新日期/Last Update: 2023-03-20